In more detail what each of these biomarker tests are measuring and how they inform treatment decisions for my type...

I'll help explain biomarker testing in lymphoma, drawing from the provided guidelines and other trusted sources.

According to the NCCN Guidelines for Patients with Follicular Lymphoma (2024), accurate testing is absolutely essential for both diagnosing and determining the right treatment approach. The guidelines emphasize that understanding your test results is important, and you should always discuss them thoroughly with your healthcare team.

From the provided guidelines, key biomarker tests typically include:

1. Blood tests
2. Bone marrow aspirate and biopsy
3. Imaging studies

However, I notice that the provided guideline excerpts don't contain detailed information about specific biomarkers. To provide you with accurate information about biomarker testing, I would need to reference additional sections from the NCCN guidelines or other trusted sources like the Leukemia & Lymphoma Society's current recommendations.

What I can confidently tell you based on the NCCN Guidelines provided:

• Your healthcare team will use a combination of test results to create your treatment plan
• It's recommended to:
  • Ask questions about your test results
  • Wait to discuss results with your doctor for complete understanding
  • Keep organized records of your test results
  • Consider bringing someone with you to appointments to help take notes

Would you like me to:

1. Focus on a specific type of biomarker test?
2. Explain more about how to discuss test results with your healthcare team?

I want to ensure I provide you with accurate, source-based information rather than making general statements without proper citation.